Total planned funding: $648,053,272
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $648,053,272 |
Organizational Types
NGO | $205,058,497 |
Private Contractor | $177,717,539 |
Unknown | $73,433,066 |
Own Agency | $64,443,954 |
University | $58,414,331 |
Implementing Agency | $51,517,955 |
FBO | $15,441,930 |
Other USG Agency | $1,826,000 |
Host Country Government Agency | $200,000 |
Multi-lateral Agency | $0 |
Program Areas
Treatment | $254,506,981 |
Prevention | $149,730,197 |
Care | $123,682,282 |
Governance and Systems | $42,179,591 |
Testing | $39,060,455 |
Management and Operations | $38,211,354 |
Budget Codes
HTXS: Treatment: Adult Treatment | $152,163,775 |
HTXD: Treatment: ARV Drugs | $92,841,506 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $88,374,904 |
HKID: Care: Orphans and Vulnerable Children | $76,315,880 |
HVCT: Testing: HIV Testing and Counseling | $39,060,455 |
HVMS: Management and Operations | $38,211,354 |
HVOP: Sexual Prevention: Other Sexual Prevention | $30,569,102 |
OHSS: Health Systems Strengthening | $22,721,194 |
HVTB: Care: TB/HIV | $20,377,793 |
HBHC: Care: Adult Care and Support | $18,148,635 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,815,025 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,763,784 |
HVSI: Strategic Information | $12,909,241 |
PDTX: Treatment: Pediatric Treatment | $9,501,700 |
PDCS: Care: Pediatric Care and Support | $8,839,974 |
HLAB: Laboratory Infrastructure | $6,549,156 |
HMBL: Biomedical Prevention: Blood Safety | $1,003,691 |
HMIN: Biomedical Prevention: Injection Safety | $203,691 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$106,979,952
Countries/Regions
University of Washington:
$79,068,015
Countries/Regions
Not Available:
$70,436,489
Countries/Regions